MDMA used as a tool to unlock autism brain chemistry secrets
NCT ID NCT07555132
First seen May 06, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This study looks at how a single dose of MDMA (the drug in ecstasy) changes oxytocin levels in the blood of 40 adults—half with autism spectrum disorder and half without. Researchers want to see if the oxytocin response differs between the two groups. MDMA is used here as a research tool, not as a treatment, to better understand how the oxytocin system works in autism.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Basel, Endocrinology, Diabetes and Metabolism
Basel, 4031, Switzerland
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.